# OnCo record rituximab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rituximab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rituximab" ;
  schema:name "Rituximab"@en ;
  schema:alternateName "Rituximab and Hyaluronidase Human"@en, "Rituxan Hycela"@en, "Rituxan / MabThera (and biosimilars)" ;
  schema:description "Rituximab was the first antibody ever approved for cancer (1997). It made chemoimmunotherapy the CLL standard for a decade, and biosimilars keep it cheap and everywhere."@en ;
  schema:url <https://onco.cc/drugs/rituximab/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Rituximab> ;
  owl:sameAs <http://www.wikidata.org/entity/Q412323> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rituximab>, <https://doi.org/10.1182/blood-2008-08-175208> ;
  onco:status "approved" ;
  onco:modality "Monoclonal antibody (anti-CD20, chimeric)" ;
  onco:approval "US 1997: Relapsed follicular lymphoma; first antibody approved for cancer", "US 2010: CLL with fludarabine and cyclophosphamide" ;
  onco:related <https://onco.cc/biomarkers/cd20-expression/> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/hetero/>, <https://onco.cc/companies/biogen/>, <https://onco.cc/companies/halozyme/>, <https://onco.cc/companies/mabion/> ;
  onco:pathways <https://onco.cc/pathways/complement-in-cancer/> ;
  onco:terms <https://onco.cc/terms/adcc/>, <https://onco.cc/terms/lymphoma-bio-lineage-antigen-cost/>, <https://onco.cc/terms/lymphoma-bio-antigen-escape/> ;
  onco:trials <https://onco.cc/trials/nct06097364/>, <https://onco.cc/trials/nct04442022/>, <https://onco.cc/trials/nct04529772/>, <https://onco.cc/trials/nct06717347/>, <https://onco.cc/trials/nct04384484/>, <https://onco.cc/trials/nct04002297/>, <https://onco.cc/trials/nct04712097/>, <https://onco.cc/trials/nct06149286/>, <https://onco.cc/trials/nct06508658/>, <https://onco.cc/trials/nct06191744/>, <https://onco.cc/trials/nct06911502/>, <https://onco.cc/trials/nct06230224/>, <https://onco.cc/trials/nct04224493/>, <https://onco.cc/trials/nct04680052/>, <https://onco.cc/trials/nct06091865/>, <https://onco.cc/trials/nct06091254/>, <https://onco.cc/trials/nct04404283/>, <https://onco.cc/trials/nct05100862/>, <https://onco.cc/trials/nct06363994/>, <https://onco.cc/trials/nct05888493/>, <https://onco.cc/trials/nct05409066/>, <https://onco.cc/trials/nct05371093/>, <https://onco.cc/trials/nct05952024/>, <https://onco.cc/trials/nct06601504/>, <https://onco.cc/trials/nct04663347/>, <https://onco.cc/trials/nct06090539/>, <https://onco.cc/trials/nct04542824/>, <https://onco.cc/trials/nct07189065/>, <https://onco.cc/trials/nct05951959/>, <https://onco.cc/trials/nct05533775/>, <https://onco.cc/trials/nct05201248/>, <https://onco.cc/trials/nct02180711/>, <https://onco.cc/trials/nct04844866/>, <https://onco.cc/trials/nct06119685/>, <https://onco.cc/trials/nct05283720/>, <https://onco.cc/trials/nct03671018/>, <https://onco.cc/trials/nct04669171/>, <https://onco.cc/trials/nct06564038/>, <https://onco.cc/trials/nct07029737/>, <https://onco.cc/trials/nct03930953/>, <https://onco.cc/trials/nct06943872/>, <https://onco.cc/trials/nct05947851/>, <https://onco.cc/trials/nct05624554/>, <https://onco.cc/trials/nct06084936/>, <https://onco.cc/trials/nct04075292/>, <https://onco.cc/trials/nct06846671/>, <https://onco.cc/trials/nct05023980/>, <https://onco.cc/trials/nct02970318/>, <https://onco.cc/trials/nct06082102/>, <https://onco.cc/trials/nct04965493/>, <https://onco.cc/trials/nct05406401/>, <https://onco.cc/trials/nct04623541/>, <https://onco.cc/trials/nct06890884/>, <https://onco.cc/trials/nct05615974/>, <https://onco.cc/trials/nct04494503/>, <https://onco.cc/trials/nct04980222/>, <https://onco.cc/trials/nct07015242/>, <https://onco.cc/trials/nct06425302/>, <https://onco.cc/trials/nct07520006/>, <https://onco.cc/trials/nct06970743/>, <https://onco.cc/trials/nct02972840/> .